Mel Hayes
2023
In 2023, Mel Hayes earned a total compensation of $2.2M as Executive Vice President, Patient Affairs at Fulcrum Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $160,300 |
|---|---|
| Option Awards | $1,561,354 |
| Salary | $471,200 |
| Total | $2,192,854 |
Hayes received $1.6M in option awards, accounting for 71% of the total pay in 2023.
Hayes also received $160.3K in non-equity incentive plan and $471.2K in salary.
Rankings
In 2023, Mel Hayes' compensation ranked 435th out of 2,271 executives tracked by ExecPay. In other words, Hayes earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 435 out of 2,271 | 81st |
Division Manufacturing | 243 out of 1,238 | 80th |
Major group Chemicals And Allied Products | 165 out of 696 | 76th |
Industry group Drugs | 163 out of 667 | 76th |
Industry Pharmaceutical Preparations | 104 out of 481 | 78th |
Source: SEC filing on April 19, 2024.
Hayes' colleagues
We found five more compensation records of executives who worked with Mel Hayes at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
2023
Robert Gould
Fulcrum Therapeutics